TY - JOUR T1 - The analysis anti-asthma drugs consumption dynamics in Yaroslavl JF - European Respiratory Journal JO - Eur Respir J VL - 40 IS - Suppl 56 SP - P1007 AU - Shamil Palyutin AU - Ilya Zilber AU - Alexander Petrochenko Y1 - 2012/09/01 UR - http://erj.ersjournals.com/content/40/Suppl_56/P1007.abstract N2 - The aim: to evaluate the dynamics of consumption of drugs for the treatment of bronchial asthma (BA) in Yaroslavl in 2008-2010.Methods: prospective cohort study; the data of healthcare and pharmacy department. There were chosen 4 groups of drugs: inhaled corticosteroids (ICS), long-acting beta-agonists (LABA), short-acting bronchodilators (SABD), combination drugs (ICS/LABA); also consumption of beclomethasone (B), fluticasone (F), fluticasone/salmeterol (FS) and budesonide/formoterol (BF) was estimated.Results: in 2008 more than 74% of patients had moderate and severe asthma requiring mandatory prescription of ICS, including combination ICS with LABA, in accordance with international guidelines for BA. In 2010 the share of such patients has increased to 77.5 percent. In 2008 the share of patients receiving ICS was 40%, in 2009 - 42%, in 2010 - 39%. LABA consumption slightly decreased - 7%, 8% and 4%, respectively. The use of SABD had a slight tendency to increase: 12%, 16%, 19%. It should be noted that the number of registered patients with BA in the city has not significantly increased (in 2008 - 7308, in 2010 - 7426). In 2004, patients with BA received 11775 packs of B, 4(!) packs of fluticasone F, 36(!) packs FS; BF was not assigned. In 2010 intake of B was 8277 packs, increas use of F and combination drugs (F - 3590, BF - 2284, FS - 6410 packs). In 2004 patients with BA consumed 589,89 g ICS. In 2010, this volume increased to 681,93 g. In 2010, the share of the modern combined drugs increased to 27% of all anti-asthma drugs.Conclusions: the analysis of consumption of anti-asthma drugs demonstrates positive dynamics - increased use of ICS in general, and the use of modern combined preparations ICS/LABA. ER -